Physician profile
Hernan Adames
NPI 1053567016
$1,819.59
in general payments reported to CMS, 2019-2025
11 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2021: $473 · 2022: $520 · 2023: $266 · 2024: $77.34 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $371.82 | 2019-2022 | |
| Esperion Therapeutics, INC. | $345.40 | 2021 | |
| Ascendis Pharma Endocrinology INC | $197.34 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $170.72 | 2022-2025 | Ultomiris |
| Janssen Scientific Affairs, LLC | $145.80 | 2023 | Xarelto |
| Abbott Laboratories | $127.75 | 2021 | |
| Janssen Pharmaceuticals, INC | $124.55 | 2022 | |
| Shire North American Group INC | $121.24 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.42 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $15.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hernan Adames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.